NP Life Sciences Health Industry Group Inc. (ACAT) Total liabilities 2019–2023
NP Life Sciences Health Industry Group Inc. (ACAT) total liabilities at each fiscal year-end, per SEC filings.
$60,483FY2023 · since FY2019: $15,183 → $60,483
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $60,483 | -44.2% |
| FY2022 | $108,468 | +45284.1% |
| FY2021 | $239 | -98.4% |
| FY2020 | $14,762 | -2.8% |
| FY2019 | $15,183 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ACAT financial trends
ACAT RevenueACAT Net incomeACAT Net marginACAT Gross profitACAT Gross marginACAT Operating incomeACAT Operating marginACAT Operating cash flowACAT Free cash flowACAT Capital expendituresACAT Return on equityACAT Stock buybacksACAT Dividends paidACAT Total assetsACAT Shareholders’ equityACAT overview →